Brigham and Women's Hospital Researchers Discover Blood Biomarker for Lou Gehrig's Disease, Could Lead to New Treatments
8/7/2012 7:50:57 AM
Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. This finding also brings the medical community a step closer toward a new treatment for the debilitating neurological disease that affects approximately 30,000 Americans.
comments powered by